Relmada Therapeutics, Inc.

NASDAQ:RLMD

3.28 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 0000000000000000000000000000000000000000000.0010.00200.0010.0020.0020.00200.006
Cost of Revenue 000000000000000.0010000000000000000000000000000.0010.002000.0020.0020.00100.005
Gross Profit 0000000000000-0-0.001000000000000000000000000000-0000000.00100.002
Gross Profit Ratio 000000000000000000000000000000000000000000-0.0040.08900.4920.2050.1390.3410.270.252
Reseach & Development Expenses 11.14910.72113.30514.75210.45413.7415.86126.86830.52930.91325.01325.27433.99417.33214.02214.90411.2375.3244.5081.6261.8873.071.2761.2571.4210.9591.6670.1510.1660.1850.4910.2540.3640.6140.6092.1182.8662.8652.2752.0920.7190.6240.2164.2660.274000000
General & Administrative Expenses 11.868.0989.68312.07712.23912.28712.29311.8348.20814.59913.2858.9098.669.138.3836.025.9467.4335.4672.9381.821.0661.4262.2220.990.9710.8831.3060.8151.5981.7921.2821.2522.4892.1383.6041.7641.5382.3042.2933.00411.6110.0030.0150.0120.020.0040.0090.0080.0030.001
Selling & Marketing Expenses 00000000000000000000000000000000000000.021000000000.00100.00100.001
SG&A 11.868.0989.68312.07712.23912.28712.29311.8348.20814.59913.2858.9098.669.138.3836.025.9467.4335.4672.9381.821.0661.4262.2220.990.9710.8831.3060.8151.5981.7921.2821.2522.4892.1383.6041.7641.5592.3042.2933.00411.6110.0030.0150.0120.020.0050.0090.0090.0030.002
Other Expenses 0000000006.3520000000000000000000.0020.0450.0570.0570.0570.0620.0550000.01000000000000
Operating Expenses 23.00918.81922.98826.82922.69326.02728.15438.70238.73745.51238.29734.18342.65426.46222.40520.92317.18412.7579.9744.5643.7074.1362.7023.4792.4111.932.551.4570.9811.7832.2831.5361.6173.1022.7475.7224.634.4244.5784.3853.72327.5190.0030.0150.0120.020.0050.0090.0090.0030.002
Operating Income -23.009-18.819-22.988-26.829-22.693-26.027-28.154-38.702-38.737-45.512-38.297-34.183-42.654-26.462-22.405-20.923-17.184-12.757-9.974-4.564-3.707-4.136-2.702-3.479-2.411-1.93-2.55-1.457-0.981-1.783-2.283-1.536-1.617-3.102-2.747-5.722-4.63-4.424-4.578-4.385-3.723-15.985-0.003-0.014-0.012-0.019-0.004-0.009-0.009-0.002-0.001
Operating Income Ratio 000000000000000000000000000000000000000000-4.581-7.770-30.733-1.767-4.197-5.696-6.203-0.083
Total Other Income Expenses Net 1.2831.0511.161.664-0.631-0.640.624-0.356-1.5095.19-1.778-0.354-0.25-0.413-0.23-0.063-0.0821.235-1.1070.0370.0380.0130.016-3.511-0.319-0.789-0.2550.341-0.0030.1490.3010.506-0.023-0.2170.8873.2629.29310.4662.1139.836-26.115-11.8453.456-0.112-1.0830-0000-0
Income Before Tax -21.726-17.768-21.828-25.165-22.002-25.303-26.322-37.944-39.419-39.935-39.746-34.378-42.606-26.552-22.215-20.762-16.903-11.118-10.673-4.527-3.669-4.123-2.686-7.129-3.38-3.35-3.202-1.427-0.982-1.634-1.981-1.031-1.641-3.317-1.86-2.4614.6636.042-2.4635.455-29.838-27.83-0.003-0.014-0.012-0.019-0.004-0.009-0.009-0.002-0.001
Income Before Tax Ratio 000000000000000000000000000000000000000000-4.581-7.770-30.733-1.767-4.197-5.696-6.203-0.083
Income Tax Expense 0-18.819-22.988-0.027-1.321-1.363-1.208-1.115-0.828-0.387-0.33-0.159-0.2980.09-0.19-0.161-0.281-1.6390.699003.82903.6490.9691.420.397-0.0290.003-0.104-0.245-0.4490.0810.277-0.833-3.2620.0010-2.1050.0010.00303.456-0.112-1.0830-0.001000-0
Net Income -21.726-17.768-21.828-25.165-22.002-25.303-26.322-37.944-39.419-39.935-39.746-34.378-42.606-26.552-22.215-20.762-16.903-11.118-10.673-4.527-3.669-4.123-2.686-7.129-3.38-3.35-3.202-1.427-0.982-1.634-1.981-1.031-1.641-3.317-1.86-2.4614.6636.042-2.4635.455-29.838-27.83-0.003-0.014-0.012-0.019-0.004-0.009-0.009-0.002-0.001
Net Income Ratio 000000000000000000000000000000000000000000-4.581-7.770-30.733-1.767-4.197-5.696-6.203-0.083
EPS -0.72-0.59-0.72-0.84-0.73-0.84-0.87-1.26-1.31-1.33-1.4-1.8-2.44-1.56-1.34-1.28-1.05-0.73-0.72-0.4-0.38-0.5-0.36-1.11-1.08-1.07-1.02-0.46-0.31-0.54-0.66-0.34-0.55-1.11-0.62-0.861.722.25-0.922.2-14.65-25.07-0.002-0.01-0.1-0.014-0.003-0.0060-0.002-0
EPS Diluted -0.72-0.59-0.72-0.84-0.73-0.84-0.87-1.26-1.31-1.33-1.4-1.8-2.44-1.56-1.34-1.28-1.05-0.73-0.72-0.4-0.38-0.5-0.36-1.11-1.08-1.07-1.02-0.46-0.31-0.54-0.66-0.34-0.55-1.1-0.62-0.861.442.25-0.921.6-14.65-25.06-0.002-0.01-0.1-0.014-0.003-0.0060-0.002-0
EBITDA -23.009-18.819-22.988-26.829-22.062-25.387-28.778-38.346-37.228-44.35-36.519-33.828-42.403-26.049-22.174-20.86-17.101-13.991-8.867-4.563-3.706-0.306-2.7010.032-2.091-1.14-2.549-1.797-0.975-1.868-2.504-1.962-1.516-2.803-3.551-8.981-4.627-4.419-6.678-4.38-3.717-15.981-0.003-0.014-0.012-0.019-0.004-0.009-0.009-0.0020
EBITDA Ratio 000000000000000000000000000000000000000000-4.361-7.6890-30.576-1.767-4.197-5.696-6.2030.042